Key result
Non-alcoholic fatty liver disease acts as an independent risk factor and potential trigger for the development of cardiovascular diseases through shared mechanisms like insulin resistance and inflammation.
This review underscores the critical link between NAFLD and cardiovascular disease, advocating for comprehensive cardiometabolic risk factor management.
The review describes the pathogenetic mechanisms of the relationship between cardiovascular disease and non-alcoholic fatty liver disease (NAFLD), which is the rationale for selecting therapeutic targets for intervention. The role of insulin resistance, oxidative stress, inflammation, dyslipidemia, intestinal microflora, heredity in the pathological relationship between NAFLD and cardiometabolic disorders are discussed. Present-day data of domestic and foreign scientists on prevalence, etiology, pathogenesis, clinical picture and treatment of this comorbid state are presented. Information is given on the development of subclinical and clinical atherosclerosis, as well as the concept of the hepatocardial continuum. In the treatment of NAFLD, the main role is given to the elimination or correction of etiopathogenetic factors of the development of the disease, excessive body weight, obesity, insulin resistance, hyperglycemia, hyperlipidemia. Particular attention is paid to the issues of dietetic complex intervention and the influence of various nutrition components on the state of the cardiovascular system and the liver.
No takes yet. Share an insight, caveat, or question.
R. A. Eganyan (2018) conducted a review in Non-alcoholic fatty liver disease and cardiovascular diseases. Non-alcoholic fatty liver disease was evaluated. Non-alcoholic fatty liver disease acts as an independent risk factor and potential trigger for the development of cardiovascular diseases through shared mechanisms like insulin resistance and inflammation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: